KOLs are an important extension of the pharmaceutical industry. It is extremely important to have these stakeholders as an integral part of a product’s lifecycle, from R&D to market access programs. However, with more regulatory hurdles, engaging KOLs is no longer an easy feat. This case study describes how Within3 provided a community platform for a healthcare group to increase engagement with clinicians to discuss treatment options and best practices for a particular therapy.
This [platform] extends the life of other resources and provides an easy way for members to search for, discuss and share the latest clinical science.KOL Participant